expert roundtables

Prospects for Improving Outcomes in High-Risk Diffuse Large B-Cell Lymphoma

by Jeremy S. Abramson, MD, MMSc; Brad Kahl, MD; and Matthew J. Matasar, MD

The classification of high-risk diffuse large B-cell lymphoma (DLBCL) is evolving to include more biologic and genetic markers. The treatment of pa......READ MORE

LATEST IN EXPERT PERSPECTIVES

Browse More Articles